Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fran E Cook-Bolden

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Dermatological Treatment|March 23, 2025
Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel in Hispanic participants with moderate-to-severe acne: a pooled analysisValerie D Callender, Hilary Baldwin, Linda Stein Gold, et al.
The Journal of Clinical and Aesthetic Dermatology|February 18, 2017
Emerging Issues in Adult Female AcneJoshua A Zeichner, Hillary E Baldwin, Fran E Cook-Bolden, et al.
Journal of Drugs in Dermatology : JDD|July 30, 2020
Novel Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Race/EthnicityNeal Bhatia, Jonathan S Weiss, Neil Sadick, et al.
The Journal of Dermatological Treatment|July 14, 2022
Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patientsJonette Keri, Fran E Cook-Bolden, Lawrence Green, et al.
Journal of Drugs in Dermatology : JDD|October 27, 2018
Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled TrialsLawrence J Green, Francisco A Kerdel, Fran E Cook-Bolden, et al.
Journal of Drugs in Dermatology : JDD|February 21, 2018
Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin PhototypeSusan C Taylor, Fran E Cook-Bolden, Amy McMichael, et al.
Journal of Drugs in Dermatology : JDD|July 1, 2009
Topically applied physiologically balanced growth factors: a new paradigm of skin rejuvenationHema Sundaram, Rahul C Mehta, Josie A Norine, et al.
Journal of Drugs in Dermatology : JDD|January 11, 2018
Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL TrialLeon H Kircik, Janet DuBois, Zoe Diana Draelos, et al.
Journal of Drugs in Dermatology : JDD|August 6, 2011
Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trialHoward Sofen, Charles P Hudson, Fran E Cook-Bolden, et al.
The Journal of Clinical and Aesthetic Dermatology|November 17, 2016
Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 TrialsDiane M Thiboutot, Leon Kircik, Amy McMichael, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Dermatological Treatment|March 23, 2025
Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel in Hispanic participants with moderate-to-severe acne: a pooled analysisValerie D Callender, Hilary Baldwin, Linda Stein Gold, et al.
The Journal of Clinical and Aesthetic Dermatology|February 18, 2017
Emerging Issues in Adult Female AcneJoshua A Zeichner, Hillary E Baldwin, Fran E Cook-Bolden, et al.
Journal of Drugs in Dermatology : JDD|July 30, 2020
Novel Polymeric Tazarotene 0.045% Lotion for Moderate-to-Severe Acne: Pooled Phase 3 Analysis by Race/EthnicityNeal Bhatia, Jonathan S Weiss, Neil Sadick, et al.
The Journal of Dermatological Treatment|July 14, 2022
Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patientsJonette Keri, Fran E Cook-Bolden, Lawrence Green, et al.
Journal of Drugs in Dermatology : JDD|October 27, 2018
Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Controlled TrialsLawrence J Green, Francisco A Kerdel, Fran E Cook-Bolden, et al.
Journal of Drugs in Dermatology : JDD|February 21, 2018
Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin PhototypeSusan C Taylor, Fran E Cook-Bolden, Amy McMichael, et al.
Journal of Drugs in Dermatology : JDD|July 1, 2009
Topically applied physiologically balanced growth factors: a new paradigm of skin rejuvenationHema Sundaram, Rahul C Mehta, Josie A Norine, et al.
Journal of Drugs in Dermatology : JDD|January 11, 2018
Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL TrialLeon H Kircik, Janet DuBois, Zoe Diana Draelos, et al.
Journal of Drugs in Dermatology : JDD|August 6, 2011
Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trialHoward Sofen, Charles P Hudson, Fran E Cook-Bolden, et al.
The Journal of Clinical and Aesthetic Dermatology|November 17, 2016
Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 TrialsDiane M Thiboutot, Leon Kircik, Amy McMichael, et al.
Pageof 4